Last reviewed · How we verify
NCT03409952
Lutronic LaseMD for Treatment of Benign Pigmented Lesions
NA trial testing LaseMD and DUAL 1927nm Laser in Benign Pigmented Lesions in 20 participants. Completed in 25 February 2019.
20 December 2018
Quick facts
| Lead sponsor | CynosureLutronic |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 17 November 2017 |
| Primary completion | 20 December 2018 |
| Estimated completion | 25 February 2019 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- LaseMD and DUAL 1927nm Laser
- LaseMD
Conditions studied
- Benign Pigmented Lesions — all drugs for Benign Pigmented Lesions →
Sponsor
CynosureLutronic — full company profile →
Who can join
18 and older, any sex, with Benign Pigmented Lesions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Lutronic LaseMD Laser System will be evaluated for the treatment of benign pigmented lesions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03409952
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Benign Pigmented Lesions
Currently open trials in the same condition.
- NCT04208100 — Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands · NA · active not recruiting
Other CynosureLutronic trials
Trials by the same sponsor.
- NCT06117293 — Safety and Efficacy Evaluation of the Mosaic Ultra Device · NA · unknown
- NCT06152900 — Safety and Efficacy of Electronic Stimulation for Circumferential Reduction and Muscle Toning · NA · completed
- NCT04207047 — Histologic Evaluation of Tissue Following Lutronic System Exposure · NA · unknown
- NCT04208100 — Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands · NA · active not recruiting
- NCT03534609 — Lutronic Genius System for Neck Treatment · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03409952 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CynosureLutronic
- Last refreshed: 13 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03409952.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing